Gilberto Lopes Júnior

34PUBLICATIONS

265CO-AUTHORS

Medical infection agents (incl. prions)Molecular targetsPacific Peoples sport and physical activityPredictive and prognostic markersCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (34)

Sort by Publication Date:

|Jun 11, 2026

Geographic, Temporal, and Sex-Specific Trends in Mesothelioma Burden in the United States, 1990-2023.

|Apr 13, 2026

Cost comparison of osimertinib plus platinum-pemetrexed versus amivantamab plus lazertinib for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.

Gilberto de Lima Lopes, Harry Freeman, Emily Procter

|Mar 26, 2026

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

|Mar 26, 2026

Exercise Counseling and Referral Practices Among Oncology Care Physicians in Latin America: A Multinational Survey Study.

Paulo Gustavo Bergerot, Cristiane Decat Bergerot, Errol J Philip

|Mar 12, 2026

Targeting tumor suppressor gene co-mutations in EGFR-mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification.

Krishna S Gunturu, Hina Khan, Gilberto de Lima Lopes

|Dec 19, 2025

Cost-Effectiveness Analysis of Durvalumab in Limited-Stage Small Cell Lung Cancer in the United States.

Chinmay T Jani, Aysswarya Manoharan, Sunwoo Han

Pageof 6

Frequent Collaborators

Narjust Florez

Estelamari Rodriguez

Maria T Bourlon

Samuel Kareff

Jennifer R Ribeiro

Gilberto de Castro

Hirva Mamdani

Jorge J Nieva

Stephen V Liu

Auro Del Giglio

Frequent Collaborators

Narjust Florez

Estelamari Rodriguez

Maria T Bourlon

Samuel Kareff